MedTrace Logo

Performance and Safety of Otinova® Ear Spray

NCT05370209 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-11-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the performance and safety of Otinova® Ear Spray when used in the treatment of external otitis symptoms.

Conditions

  • Otitis Externa

Interventions

DEVICE

Otinova® Ear Spray

Ear spray

Sponsors & Collaborators

  • Circius Pharma AB

    lead INDUSTRY

Principal Investigators

  • Daniel Wilhelms, MD, PhD · Cordinator Medical Service AB

  • Sarah Ohlsson Maleki, MD · Öron-Näsa-Hals-Center Malmö

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2023-11-27
Completion
2024-01-29

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05370209 on ClinicalTrials.gov